Septic Shock Management
Initial Resuscitation
- Administer at least 30 mL/kg of intravenous crystalloids within the first 3 hours for patients with sepsis-induced hypoperfusion, as recommended by the Society of Critical Care Medicine 1, 2
- Continue fluid administration as long as hemodynamic factors continue to improve, using a fluid challenge technique, according to the European Society of Intensive Care Medicine 1, 2
- Target a mean arterial pressure of at least 65 mmHg in patients requiring vasopressors, as suggested by the American College of Chest Physicians 4
- Monitor for signs of adequate tissue perfusion, including capillary refill time, extremities temperature, and urine output, as recommended by the Society of Critical Care Medicine 4, 5
- Consider albumin in addition to crystalloids when patients require substantial amounts of crystalloids, according to the European Society of Intensive Care Medicine 1, 2
- Avoid hydroxyethyl starches for fluid resuscitation due to potential renal and coagulatory side effects, as recommended by the Society of Critical Care Medicine 1, 4
Antimicrobial Therapy
- Administer intravenous broad-spectrum antibiotics within the first hour of recognizing septic shock, as recommended by the Infectious Diseases Society of America 2, 6
- Obtain appropriate microbiologic cultures before starting antimicrobial therapy, including at least two sets of blood cultures, but do not delay antibiotic administration, according to the American College of Chest Physicians 6, 3
- Select broad-spectrum antibiotics that cover all likely pathogens based on the suspected source of infection, as suggested by the Society of Critical Care Medicine 6
- For septic shock, use combination therapy with at least two antibiotics from different classes targeting the most likely bacterial pathogens, according to the Infectious Diseases Society of America 2, 6
Vasopressor Support
- Initiate vasopressors if hypotension persists despite fluid resuscitation, as recommended by the Society of Critical Care Medicine 4, 3
- Consider administering intravenous hydrocortisone or prednisolone to patients requiring escalating dosages of vasopressors, according to the European Society of Intensive Care Medicine 4
Source Control
- Identify the specific anatomic source of infection as rapidly as possible, as recommended by the Society of Critical Care Medicine 1, 2
- Implement source control interventions, such as drainage or debridement, as soon as medically and logistically practical, ideally within the first 12 hours after diagnosis, according to the Infectious Diseases Society of America 1, 2
- Remove any intravascular access devices that may be the source of infection after establishing alternative vascular access, as suggested by the Society of Critical Care Medicine 1, 2
Ongoing Management
- Reassess antimicrobial therapy daily for potential de-escalation, as recommended by the Society of Critical Care Medicine 1, 2
- De-escalate combination therapy within the first few days in response to clinical improvement and/or evidence of infection resolution, according to the Infectious Diseases Society of America 2, 6
- Typical duration of antibiotic therapy is 7-10 days, though longer courses may be necessary for slow clinical response, undrainable infection sites, or specific pathogens, as suggested by the American College of Chest Physicians 2, 6
Common Pitfalls to Avoid
- Delaying antimicrobial administration beyond one hour, as mortality increases by 8% for each hour delay, according to the Society of Critical Care Medicine 5
- Inadequate fluid resuscitation or failure to reassess fluid status after initial resuscitation, as recommended by the European Society of Intensive Care Medicine 3
- Failure to identify and control the source of infection promptly, according to the Society of Critical Care Medicine 1, 2
- Continuing broad-spectrum antibiotics without de-escalation once culture results are available, as suggested by the Infectious Diseases Society of America 2, 6
- Using hydroxyethyl starches for fluid resuscitation due to potential renal and coagulatory side effects, as recommended by the Society of Critical Care Medicine 1, 4